A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 954 participants.
Also called NCT07595549
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 954 participants
- Sponsor
- Registry
-
NCT07595549 -
2026-525318-75-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Brazil, Canada, France, Germany, Italy, Japan, Mexico, Poland, South Korea, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT07595549. Randomized; double masking; primary purpose treatment. Start 2026-06-10 (actual); primary completion 2028-05-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Condition
- Obesity
- Condition
- Overweight and/or Obesity
- Condition
- Overweight
- Intervention (Drug)
- PF-08653944
- Intervention (Other)
- Placebo
- Lead sponsor
- Pfizer
Record details
- Record id
cardio:ct-nct07595549- Content hash
75dbbfc48b5941551135acccd91f8e080f79b5fecea52e71831f0ee99d269b87